SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on Biotechnology

    Archives: Biotechnology

    OncoVista posts 3Q loss  Nov 20, 2009
    The company also receive a portion of research and development revenues through a partnership between the German Federal Ministry for Education and Research and a public-private consortium of biotechnology companies. AdnaGen is a member of this consortium and is receiving part of a 200 million Euro ($300 million) government grant. (San Antonio Business Journal, TX)

    Racing to the future  Nov 20, 2009
    Four areas are at the core of the progress we can expect: deep and pervasive computing, robotics, biotechnology and nanotechnology. Discoveries in these areas are already changing our lives and are critical to addressing the global challenges ahead. (Sydney Morning Herald -- Business)

    Ubidyne, Tucson firms win at GCOI  Nov 20, 2009
    Arizona State University s Polytechnic campus in Mesa was named Innovator of the Year in Academia for work being done by Qiang Hu and Milton Sommerfield as co-directors of the Laboratory for Algae Research and Biotechnology. Craig Barrett, former chairman, CEO and president of , received the People s Choice Lifetime Achievement Award, sponsored by. (Phoenix Business Journal, AZ)

    Nigeria: GMO Rice - U.S. Suit Confirms Contamination in Country, ERA  Nov 20, 2009
    Reacting to the development, ERA/FoEN said the US litigation showed the extent the biotechnology industry and its allies will go to "undermine food supplies" to unsuspecting consumers especially in Africa where there are weak biosafety laws. Relevant Links. (allAfrica.com)

    Oil from Biotech Soybeans Increases Key Omega-3 Fatty Acid in Humans  Nov 20, 2009
    19, 2009) Oil from soybeans modified through biotechnology increased levels of omega-3 eicosapentaenoic acid (EPA) in red blood cells according to research presented at the American Heart Association's Scientific Sessions 2009. See Also. (Science Daily)

    Taking Aim at Hard-to-Treat Fungal Infections  Nov 20, 2009
    The WPI research team led by Reeta Prusty Rao, PhD, assistant professor of biology and biotechnology, developed the new model using the microscopic soil worm Ceanorhaditis elegans (C. elegans) as a test host which is then infected with the fungus Saccharomyces cerevisiae (S. cerevisiae) ... In their recently published study, Prusty Rao's team, working in collaboration with Samuel Politz, PhD, associate professor of biology and biotechnology at WPI, used a range of available genetic tools to... (Science Daily)

    Families of Lexus crash victims express than...  Nov 20, 2009
    A scientist and researcher at various biotechnology and pharmaceutical companies, she was a senior research assistant at Ambrx. Chris Lastrella, 38, was born in Hawaii and worked as a enrollment adviser at Ashford University in Sabre Springs. (San Diego Union-Tribune)

    S.D. needs partners for biofuel endeavor  Nov 20, 2009
    A panel of experts said yesterday at a meeting of the local biotechnology group BioCom that such deals will be critical to providing the billions of dollars in capital necessary to get the industry up to commercial scale. Larger companies will also be necessary for distribution power and other infrastructure required for commercialization. (San Diego Union-Tribune)

    STEM CELLS: THE FIRST HUMAN TRIAL...  Nov 20, 2009
    box").removeAttr("style"); }); }); People suffering from a form of incurable blindness could soon become the first patients in the world to benefit from a new and controversial transplant operation using stem cells derived from spare human embryos left over from IVF treatment. Scientists working for an American biotechnology company yesterday applied for a licence to carry out a clinical trial on patients in the US suffering from a type of macular degeneration, which causes gradual loss of... (The Drudge Report)

    XOMA Receives NASDAQ Determination Letter  Nov 20, 2009
    XOMA discovers, develops and manufactures novel antibody therapeutics for its own proprietary pipeline as well as through license and collaborative agreements with pharmaceutical and biotechnology companies, and under its contracts with the U.S. government ... Actual results could differ materially from those anticipated due to certain risks inherent in the biotechnology industry and for companies engaged in the development of new products in a regulated market ... These risks, including those... (Primezone Releases)

    How Plant Stem Cells Guard Against Genetic Damage  Nov 19, 2009
    Nick Fulcher and Robert Sablowski, with funding from the Biotechnology and Biological Sciences Research Council (BBSRC), set out to discover what these safeguards could be. By using X-rays and chemicals they were able to induce damage to DNA, and found that stem cells were much more sensitive to DNA damage than other cells. (Science Daily)

    * Straight talk on GM crops crucial  Nov 19, 2009
    Taiwan is highly dependent on advanced science to develop its biotechnology, and is also engaged in free trade under the WTO framework ... Tuan-hua David Ho is an academician of Academia Sinica and former director-general of the National Science and Technology Program on Agriculture Biotechnology. (Taipei Times, Taiwan -- World)

    PPD buying BioDuro in China expansion  Nov 19, 2009
    BioDuro is also a drug development contractor, providing services to the biotechnology industry. It has a 110,000-square-foot laboratory in Beijing. (Yahoo News -- Pharmaceutical Industry News)

    GEN reports on enhancing the applications of qPCR  Nov 19, 2009
    Genetic Engineering chnology News (), which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Clinical Research and Diagnostics. (EurekAlert!)

    Enzon sells specialty drug business for $300M  Nov 19, 2009
    In 2008, Enzon announced plans to spin off its biotechnology business into an independent company so it could focus on developing treatments for cancer. It canceled those plans in December due to the weak state of the financial markets. (Yahoo News -- Pharmaceutical Industry News)

    Judges: Seattle Biotech Can Pursue $23M Claim  Nov 19, 2009
    Seattle biotechnology firm Cell Therapeutics Inc. can pursue claims for nearly $23 million against a former consultant, a federal appeals court ruled Wednesday. The ruling by a three-judge panel of the 9th U.S. Circuit Court of Appeals overturned the ruling of a judge in Seattle and created a new interpretation of law surrounding fraud cases brought on behalf of the government. (ABC News -- Wire)

    Neurocrine shares plunge on FDA rejection  Nov 19, 2009
    Shares in plummeted to their lowest level in more than five years, illustrating the peril faced by small companies -- including dozens of Boston area biotechnology firms -- whose value rests on a single product that has not yet reached the market. The FDA turned down an application by the 14-year-old San Diego company and , the world's largest drug maker, to sell a 15 milligram extended-release version of the insomnia drug Indiplon. (Yahoo News -- Sleep and Sleep Disorders)

    Medicine gobbles up research money  Nov 19, 2009
    In contrast, the number of chemists working in biotechnology, medical and pharmaceutical specialties nearly tripled over that time period. In 2005, almost one in three chemists under 40 years old worked in the pharmaceutical industry. (Atlanta Journal-Constitution -- Opinion)

    * COA to build new aquaculture center  Nov 19, 2009
    The Council of Agriculture (COA) announced yesterday that it would build a new Aquaculture Research and Export Center as part of the Pingtung Agricultural Biotechnology Park. Officials said that the new center X which is expected to be completed by 2011 X will attract research professionals and help the industry increase its share in the US$30 billion worldwide ornamental fish and fish breeding market. (Taipei Times, Taiwan -- World)

    Cancers' Sweet Tooth May Be Weakness  Nov 19, 2009
    Biotechnology companies are already searching for ways to do so, Chen says. Scientists from Dana Farber Cancer Institute, Yale University, Cell Signaling Technology Inc. and Novartis contributed to the paper. (Science Daily)

    4-Star Stocks Poised to Pop: Alkermes  Nov 18, 2009
    Market-trouncing returns could be written in these stars. By Brian D. Pacampara. (MSNBC -- Business)

    China pushes solar, wind power development  Nov 18, 2009
    He points to biotechnology firms such as and , which have grown into innovation leaders in the drug industry. Likewise, data communication usurped telecommunication, and new entrants such as challenged old giants such as AT&T, Salzman says. (USA Today -- Tech)

    Qiagen Is Poised for More Purchases After $2 Billion Spree in Last 5 Years  Nov 18, 2009
    Nov. 18 (Bloomberg) -- , the Dutch biotechnology company that has spent about $2 billion on acquisitions since 2004, is armed for yet more takeovers as it seeks additional gene-based tools to predict disease ... Its shares have advanced almost 30 percent this year, more than twice the rate of the Nasdaq Biotechnology Index. (Bloomberg -- Germany)

    PolyMedix completes $20M stock offering  Nov 18, 2009
    biotechnology company sold units, priced at $1 each, consisting of one share of PolyMedix common stock and one five-year warrant to purchase 0. 30 of a share of PolyMedix common stock at $1. (Philadelphia Business Journal, PA)

    Mouse cloned to cure Parkinson's  Nov 18, 2009
    The embryonic "stem cells", reports the journal Nature Biotechnology, were grown into new tissue which was implanted into the mouse brain. However, many obstacles stand in the way of human treatments, say experts. (Yahoo News -- Parkinson's Disease)

    * All-English curriculums necessary  Nov 18, 2009
    However, based on the examples of wafer foundry and biotechnology, the truth is that we are still far behind developed countries ... Why would an African student spend a few years first mastering Chinese in order to study biotechnology in Taiwan. (Taipei Times, Taiwan -- World)

    Movie studio plan is in LNRs script  Nov 18, 2009
    The redevelopment plan for the base includes the construction of 2,855 homes, a hotel, an 18-hole golf course, a conference center, boutique shops, restaurants, hiking baths, walkways, recreational fields, and a two million square foot commercial complex to accommodate a pharmaceutical company or biotechnology firm. LNR plans to build these amenities over a 14-year period, but construction has been stayed in part because a transfer of 830 acres of land by the U.S. Navy to the state agency that... (Weymouth News, MA)

    Entrepreneurs gather to share lessons  Nov 18, 2009
    Walters described the operations of the Nashville Business Incubation Center, which provides management and technical assistance, shared support services, and professional advisement to start-up businesses in fields from biotechnology to janitorial services. Nashville Business Journal hosts Shaping a Better Nashville quarterly. (Nashville Business Journal, TN)

    Capstone Therapeutics Announces Transfer to Nasdaq Capital Market  Nov 18, 2009
    Capstone Therapeutics (trade name of OrthoLogic Corp.) is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. The Company is focused on development and commercialization of two product platforms: AZX100 and Chrysalin(R) (rusalatide acetate or TP508). (Primezone Releases)

    Novartis, SBC sign pact on biotech venture  Nov 18, 2009
    Malaysias biotechnology sector is still in the nascent stage, but the growing number of participants at the BioMalaysia Conference ition 2009 is testament to its rising importance ... Malaysian Biotechnology Corp (BiotechCorp) is also involved in the project, which has been billed the first of its kind public-private partnership initiative in the area of drug discovery. (The Star Online, Malaysia -- Business)

    European R&D Growth Outstrips the U.S.  Nov 18, 2009
    But the scoreboard also highlights the diverging nature of Rding on both sides of the Atlantic, with the US clearly leading the way in higher-intensity Rors such as biotechnology, while the EU is more dominant in medium-intensity sectors such as automobiles ... In the US, investment growth was driven largely by high-intensity Rors such as pharmaceuticals, biotechnology and computer services sectors, consolidating an already existing trend. (BusinessWeek)

    Gauteng's bigger budget  Nov 18, 2009
    An amount of R400-million was set aside for agriculture and the implementation of biotechnology strategy. An additional R3. (iAfrica.com)

    Evotec Wins German Government Research Grant  Nov 18, 2009
    Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Evotec has long-term discovery alliances with partners including Boehringer Ingelheim, CHDI, Novartis, Ono Pharmaceutical and Roche. (Primezone Releases)

    PM: National innovation centre to be launched early 2010  Nov 17, 2009
    "The focus of the MyNIC is innovation across the board, not only in biotechnology but also in the information, communication and technology (ICT) industry, animation as well as agriculture and other industries," he said at a press conference after the official launch of the BioMalaysia Conference and Exhibition 2009 here on Tuesday ... Najib said that Malaysia had the means to be a regional biotechnology hub based on the positive growth of the industry ... "This involves a field which is... (The Star Online, Malaysia -- Business)

    Targacept joins NASDAQ biotech index  Nov 17, 2009
    will be added to the NASDAQ Biotechnology Index as of next Monday, Nov. 23, according to an announcement from the firm. The index includes securities from biotech and pharmaceutical companies that trade on the NASDAQ exchange and meet certain eligibility criteria. (Triad Business Journal, NC)

    Trubion shakes up management  Nov 17, 2009
    The Seattle biotechnology company (NASDAQ: TRBN), which is developing drugs for treating autoimmune and inflammatory diseases and cancer, of $6. 2 million, or 33 cents a share, earlier this month. (Puget Sound Business Journal, WA)

    Dyadic narrows losses as revenue shrinks  Nov 17, 2009
    The Jupiter-based producer of industrial enzymes and developmental biotechnology company (Pink Sheets: DYAI) narrowed its losses to $654,425, or 2 cents a share, in the third quarter, from a loss of $2. 6 million, or 9 cents a share, in the same quarter a year ago. (South Florida Business Journal, FL)

    Mida reviews investment policy  Nov 17, 2009
    And in line with the direction of the new economic model for the country, Jalilah revealed that the revised investment policy would focus on new growth areas such as biotechnology, renewable energy, fine chemicals, advanced electronics, petrochemical, machinery and equipment as well as selected services industries. Over the last one year, the onslaught of the global economic crisis had resulted in a significant decline in the value of investments in Malaysia. (The Star Online, Malaysia -- Business)

    Bullish outlook for biotechnology next year  Nov 17, 2009
    KUALA LUMPUR: The biotechnology industry sees a better business scenario next year driven by the improving local and global economy, says Malaysian Biotechnology Corporation (BiotechCorp) chief executive officer Datuk Iskandar Mizal Mahmood. There are more investment coming from the private sector nowadays as they are aware of the potential in the industry, he told StarBiz on the sideline of the fourth biotechnology International Advisory Panel (IAP) meeting yesterday, which was in conjuction... (The Star Online, Malaysia -- Business)

    FDA won’t give its OK until Genzyme corrects deficiencies  Nov 17, 2009
    yesterday said US regulators are delaying approval of Lumizyme, its drug to treat the rare genetic disorder Pompe disease in adults, until the Cambridge biotechnology company solves persistent problems at its cell culture manufacturing plant in Allston ... Christopher J. Raymond, a senior biotechnology analyst at the Chicago financial firm Robert W. Baird & Co., yesterday reiterated his neutral rating on Genzyme s stock. (Boston Globe)

    Job training center opens at UMB BioPark  Nov 17, 2009
    Kathleen Kennedy Norris, BCCC coordinator of biotechnology and LSI s on-site director, said 18 students have already been recommended to interview with Massachusetts-based Biomere LLC for potential employment and training as part of a new laboratory animal care facility and certificate to be offered at LSI. Biomere has space at the park. Housing the Life Sciences Institute at the BioPark is about creating jobs and new opportunity for students who go here and residents who live here, Mikulski... (Baltimore Business Journal, MD)

    Golden glow - Eating fruit beats suntan for complexion  Nov 17, 2009
    Page last updated at 16:40 GMT, Monday, 16 November 2009. Golden glow' is healthiest look. (BBC News -- Health)

    Durhams Addrenex sells for $29M  Nov 17, 2009
    Addrenex has also received $160,000 in loans from the North Carolina Biotechnology Center. Sciele will keep Addrenex in Durham, and the company will operate as a wholly owned subsidiary of Sciele. (Raleigh Triangle Business Journal, NC)

    Astrotech doing more research in space  Nov 17, 2009
    Astrogenetix is a biotechnology company formed to commercialize biotechnology projects processed in microgravity environments. Most Read Stories. (Austin Business Journal, TX)

    Biotech crops cause big jump in pesticide use: report  Nov 17, 2009
    But the Biotechnology Industry Organization, of which Monsanto is a member, said the popularity of herbicide-resistant crops showed their value outweighs any associated detriments ... The groups additionally criticized the agricultural biotechnology industry for claiming that higher costs for genetically engineered seeds are justified by multiple benefits to farmers, including decreased spending on pesticides. (Scientific American)

    Pharmaceutical firms view Malaysia as ideal location for research  Nov 17, 2009
    This also augurs well for Malaysia that aspires to be a successful global biotechnology hub, he said, adding that the country had the competitive edge as it had the necessary resources ... Bio nexus programme is a key element of the National Biotechnology Policy ... Currently the biotechnology industry contributes 2. (The Star Online, Malaysia)

    Singularity University Gives Execs a View of the Future  Nov 17, 2009
    Gillam was reminded of this recently during a nine-day boot camp aimed at instructing professionals on how robotics, nanotechnology, biotechnology, and other cutting-edge disciplines are affecting industries ... During the first few days, participants heard from thinkers and practitioners in six key areas: artificial intelligence and robotics; nanotechnology; biotechnology and bioinformatics; medicine and human-machine interfaces; networks and computing systems; and energy and environment... (BusinessWeek)

    Five-step check for nano safety  Nov 17, 2009
    The group of experts says that if the global research community can take advantage of the safety infrastructure already in place for biotechnology and computing, then nanotechnology has a rosy future. But Dr Maynard, from the Woodrow Wilson International Center for Scholars in Washington DC, and colleagues say that the way science is carried out means it is ill-equipped to address novel risks from emerging technologies. (Yahoo News -- Nanotechnology)

    Biosensor to Help Enlist Cancer Resistance Fighters?  Nov 17, 2009
    "Many pharmaceutical companies, instead, see a potential application in the field of industrial biotechnology and have [shown] interest in using this technology to improve some critical steps commonly found, for instance, in the production of monoclonal antibodies," notes Bocchi. A start-up company, Mindseeds Laboratories, was founded with the aim of commercialising the work, but that will take time and further research. (Science Daily)

    Palm Oil Board achieves another first in oil palm genomes development  Nov 16, 2009
    MPOB unit Advanced Biotechnology Breeding Centre (ABBC) and its consortium partners have sequenced, assembled and annotated to a certain extent, the three oil palm genomes with 68 times coverage for combined sequences and almost 94% completeness. The consortium members include US-based Orion Genomics, South Korea-based Macrogen Inc, MOgene LC and the Genome Centre at Washington University, and Australia-based GeneWorks Pty Ltd.. (The Star Online, Malaysia -- Business)

    Threshold Pharmaceuticals 3Q loss widens on costs  Nov 16, 2009
    Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses. The company lost $6. (Yahoo News -- Pharmaceutical Industry News)

    Researchers find potential treatment for Huntington's disease  Nov 16, 2009
    UBC has particular strengths in biotechnology, ranks in the top 10 universities in North America and number one in Canada for commercializing research and for its patent activity in the life sciences. For more information, visit. (EurekAlert!)

    Paul C. Zamecnik, at 96; discoveries helped revolutionize biochemistry  Nov 16, 2009
    His research led many companies to work exclusively on antisense biotechnology. He was forced into mandatory retirement from Harvard at age 65 and went to the Worcester Foundation for Biomedical Research, where he worked on blocking HIV with an antisense oligonucleotide. (Boston Globe)

    Biotech sector fundamentals expected to remain favourable  Nov 16, 2009
    PETALING JAYA : Many of the biotechnology industry s fundamentals, such as the number of products in clinical trials, new product approvals, profitable biotech companies and industry mergers & acquisitions, are expected to remain favourable, according to Malaysian Biotechnology Corp Bhd (BiotechCorp) ... Chief executive officer Datuk Iskandar Mizal Mahmood said: Within four years of our establishment, we have developed 135 biotech companies under the BioNexus status, across agricultural,... (The Star Online, Malaysia -- Business)

    Najib: BioNexus-status companies to increase by 50 in next 2 years  Nov 16, 2009
    "The 135 biotechnology companies have had a total approved investment of more than RM1.51 billion since the inception of the National Biotechnology Policy in 2005, with a revenue of more than RM700 million, and involving 2,260 knowledge workers," he told reporters after chairing the Biotechnology International Advisory Panel meeting held in conjunction with Bio Malaysia 2009 here on Monday ... Among specific proposals made at the meeting are the need to set up power house research centres that... (The Star Online, Malaysia)

    On health care, many in House spoke with lobbyists’ voice  Nov 15, 2009
    Statements by more than a dozen lawmakers were ghostwritten, in whole or in part, by Washington lobbyists working for Genentech, one of the world s largest biotechnology companies ... Republicans opposed the bill, but praised a provision that would give the Food and Drug Administration authority to approve generic versions of expensive biotechnology drugs, along the lines favored by brand-name companies like Genentech ... In separate statements using language suggested by the lobbyists,... (Boston Globe)

    Talecris to create 259 jobswith $269M Clayton expansion  Nov 14, 2009
    We re excited to continue expanding in a region that has been so supportive of the biotechnology industry. The One North Carolina Fund grant requires a match by local governments. (Raleigh Triangle Business Journal, NC)

    Morrisville biotech raises $1M - almost  Nov 14, 2009
    a Morrisville biotechnology company, needs just $1 more to close out a $1 million round of debt financing, according to documents filed with the. Investors in the company include of Durham and. (Raleigh Triangle Business Journal, NC)

    Affymax 3Q loss narrows partnership payments  Nov 14, 2009
    Biotechnology company Affymax Inc. said Wednesday its third-quarter loss narrowed on a boost in payments from its partner Takeda Pharmaceutical on the anemia drug candidate Hematide. The company lost $18. (Yahoo News -- Pharmaceutical Industry News)

    Enzon sells specialty drug business for $300M  Nov 14, 2009
    In 2008, Enzon announced plans to spin off its biotechnology business into an independent company so it could focus on developing treatments for cancer. It canceled those plans in December due to the weak state of the financial markets. (Yahoo News -- Pharmaceutical Industry News)

    More contamination troubles for Genzyme  Nov 14, 2009
    the Cambridge biotechnology giant that has spent five months scrambling to regain its footing after detecting a virus at its Allston plant, is facing a new contamination problem: bits of steel, rubber, and fiber found in drugs made by the company and shipped from the same site ... Geoff McDonough, senior vice president and general manager for genetic diseases at Genzyme, said particles are an issue for all biotechnology manufacturers. (Boston Globe)

    J.C. Penney, Disney, Genzyme Are Big Movers  Nov 14, 2009
    Federal health regulators have found tiny particles of trash such as steel, rubber and fiber in drugs made by the biotechnology firm. Petsmart Inc., up 97 cents at $25. (ABC News -- Wire)

    Spherix Incorporated to Webcast Formal Remarks From Annual Meeting of Shareholders  Nov 14, 2009
    Nov. 13, 2009 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq: - ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will host a conference call on Tuesday, November 17th, at 9:00 AM ET, to provide the formal comments from its Annual Meeting of Shareholders ... Its Spherix Consulting subsidiary provides scientific and strategic support for... (Primezone Releases)

    Harper era begins with comeback win  Nov 14, 2009
    To persuade the state's largest biotechnology company to expand its Clayton plant, state and local officials promised a package of tax breaks and other financial aid worth nearly $20 million. The new Wake County school board majority has an unexpected foe: Clay Aiken. (News & Observer -- Business)

    Semi-Annual Changes to the NASDAQ Biotechnology Index  Nov 14, 2009
    NEW YORK, Nov. 13, 2009 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq: - ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index(R) (Nasdaq: - ), which will become effective with the market open on Monday, November 23, 2009 ... All securities are classified according to the Industry Classification Benchmark (ICB) as either biotechnology or pharmaceutical ... For more information about the NASDAQ Biotechnology Index, including eligibility criteria,... (Primezone Releases)

    Bits of steel, rubber found in Genzyme drugs  Nov 14, 2009
    WASHINGTON - Federal health regulators say they have found tiny particles of trash in drugs made by biotechnology firm Genzyme. The Food and Drug Administration says bits of steel, rubber and fiber in drug vials could cause serious adverse health effects for patients. (MSNBC -- Health)

    Neurocrine shares plunge on FDA rejection  Nov 14, 2009
    Shares in plummeted to their lowest level in more than five years, illustrating the peril faced by small companies -- including dozens of Boston area biotechnology firms -- whose value rests on a single product that has not yet reached the market. The FDA turned down an application by the 14-year-old San Diego company and , the world's largest drug maker, to sell a 15 milligram extended-release version of the insomnia drug Indiplon. (Yahoo News -- Sleep and Sleep Disorders)

    Talecris to Invest $268.7 Million in NC Plant  Nov 14, 2009
    Biotechnology manufacturer Talecris Biotherapeutics said Friday it will spend $268. 7 million and get state and local incentives to expand a plant in Clayton, N.C.. (ABC News -- Wire)

    Md. biotech plans to hire 125 in Baltimore  Nov 14, 2009
    Emergent BioSolutions has bought a 55,000 square foot space in East Baltimore and plans to hire as many as 125 people for a biotechnology manufacturing facility there ... State economic development leaders said the sale will help build and sustain the region s growing biotechnology community ... Maryland is continuing to strengthen its place as a global hub for an emerging biotechnology industry by helping to grow industry leaders like Emergent BioSolutions, Gov. Martin O Malley said in a... (Baltimore Business Journal, MD)

    Isakson will help honor small business of year  Nov 14, 2009
    WASHINGTON --- Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues. The Food and Drug Administration said Friday that bits of steel, rubber and fiber found in vials of drugs used to treat rare enzyme disorders could cause serious adverse health effects for patients. (The Augusta Chronicle)

    Halozyme takes bigger loss on testing expenses  Nov 14, 2009
    SAN DIEGO Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period. Halozyme lost $13. (Yahoo News -- Pharmaceutical Industry News)

    San Joaquin Valley receives $2m grant for training  Nov 13, 2009
    A $2 million state grant will help train people in the San Joaquin Valley to work in water technology, renewable energy, food processing, agriculture technology and biotechnology -- industries closely tied to the region's farming economy. The grant comes from the California Labor and Workforce Development Agency and goes to the California Partnership for the San Joaquin Valley. (Fresno Bee)

    Sweet Solution To Energy Production  Nov 13, 2009
    18, 2007) A new analysis has concluded that use of existing biotechnology in the production of so-called bulk chemicals could reduce consumption of non-renewable energy and carbon emissions by 100 percent. (July 25, 2008) Converting livestock manure into a domestic renewable fuel source could generate enough electricity to meet up to three percent of North America's entire consumption needs and lead to a significant. (Science Daily)

    Australia pledges $70 million for research projects in India  Nov 13, 2009
    The fund is already supporting 50 projects cutting across scientific disciplines, including astronomy, climate change and evolution, malaria vaccines, the impact of global warming on agriculture, water management, computing and biotechnology. Energy cooperation has become an important area of cooperation between the two countries. (India Times, India)

    Rising market tide fails to lift some Mass. firms  Nov 13, 2009
    Biotechnology stocks often swim against the market s tide ... But this year most biotech stocks have been big winners, with the leading Amex Biotechnology stock index up 64. (Boston Globe)

    Prince Georges identifies sites for new biotech cluster  Nov 13, 2009
    The consultants recommended eventually building a new biotechnology park on a 250-acre Beltsville plot partly owned by and the. Most Read Stories. (Washington Business Journal, DC)

    You want pesticides with that? Why less means more  Nov 13, 2009
    Search brisbanetimes. You want pesticides with that. (Sydney Morning Herald -- Opinion)

    SPECIAL REPORT: Welcome to the Clone Farm  Nov 13, 2009
    Still, ViaGen and the Biotechnology Industry Organization have helped to create a supply chain management program to track clones from birth to death. ViaGen also gives farmers the incentive to disclose when and where they cull a clone by holding a deposit until the clone's owner can verify that the animal has been euthanized or slaughtered for meat. (The Star Online, Malaysia)

    Nano Bubble Gum For Enhancing Drug Delivery In Gut  Nov 13, 2009
    Working with a Bay-area biotechnology company, she is making devices that are sort of like spiny beads filled with drugs. The spines on these beads are silicon nanowires designed to form an adhesive interface with the tiny, hair-like cilia that cover the cells lining the gut. (Science Daily)

    Five-step check for nano safety  Nov 13, 2009
    The group of experts says that if the global research community can take advantage of the safety infrastructure already in place for biotechnology and computing, then nanotechnology has a rosy future. But Dr Maynard, from the Woodrow Wilson International Center for Scholars in Washington DC, and colleagues say that the way science is carried out means it is ill-equipped to address novel risks from emerging technologies. (Yahoo News -- Nanotechnology)

    * Universal Vision inks deal with university in Fujian  Nov 13, 2009
    Universal Vision Biotechnology Co (j), Taiwans first biotech firm to list its shares on the GRETAI Securities Market, yesterday signed a pact with a medical university in Fujian Province, paving the way for expansion into China. This partnership will help us train the necessary human resources, letting us get ready to move into the mainland market, chairman Ou Shu-fong (Q) said on the sidelines of the signing ceremony. (Taipei Times, Taiwan -- World)

    Mouse cloned to cure Parkinson's  Nov 13, 2009
    The embryonic "stem cells", reports the journal Nature Biotechnology, were grown into new tissue which was implanted into the mouse brain. However, many obstacles stand in the way of human treatments, say experts. (Yahoo News -- Parkinson's Disease)

    PolyMedix announces public offering  Nov 12, 2009
    Biotechnology company Inc. on Wednesday announced a public equity offering of up to $21 million. Radnor, Pa. (Philadelphia Business Journal, PA)

    J&J to slash 7,000 to 8,000 jobs  Nov 12, 2009
    In May, Jed to buy cancer drug developer Cougar Biotechnology for 970 million in cash. Like rival drugmakers, Jtruggling to refill its pipeline with new drugs to offset sales lost to generic competition and flagging revenue from older products, including some dogged by safety concerns. (Yahoo News -- Pharmaceutical Industry News)

    Weather sideswipes Rudd in India visit  Nov 12, 2009
    Today he will visit India's Energy Research Institute and its biotechnology laboratories and give $50 million over five years towards the Australia-India Strategic Research Fund, which supports 50 projects across such areas as renewable energy, medicine and agriculture. With an Australia inquiry pending into the 10-week oil and gas leak off the West Australian coast, Mr Rudd will today announce $400,000 towards a project that is trying to develop the use of bacteria to clean up oil spills in the... (Sydney Morning Herald -- World)

    Archives: Biotechnology

    Back to Biology News

[ Terms Of Use | Privacy | About ]
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2009